Related references
Note: Only part of the references are listed.Improvement of SARS-CoV-2 symptoms following Guselkumab injection in a psoriatic patient
F. Benhadou et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Evolution of COVID-19 infection in four psoriatic patients treated with biological drugs
A. Conti et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
SARS-CoV-2 infection in a psoriatic patient treated with IL-17 inhibitor
R. Balestri et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2020)
Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis Results From the Psoriasis Longitudinal Assessment and Registry (PSOLAR)
Robert E. Kalb et al.
JAMA DERMATOLOGY (2015)
Share Paper
